Company / SG&A per Share
Whitehawk Therapeutics, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.49
FY2025
5-year range
$0.83 / $7.40
FY2021-FY2025
Trend
-17.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 8 years, ranging from $0.24 in FY2020 to $7.40 in FY2022.
Based on SEC 10-K filings.
1.49 in FY2025 with a 5-year CAGR of +44.0%.
Improved from $1.64 to $1.49 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -41.4%
- 5-Year CAGR
- +44.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 17.9% year-over-year.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.49 | -17.9% |
| FY2024 | $1.81 | +10.3% |
| FY2023 | $1.64 | -77.8% |
| FY2022 | $7.40 | +787.5% |
| FY2021 | $0.83 | +247.1% |
| FY2020 | $0.24 | -27.7% |
| FY2019 | $0.33 | -2.7% |
| FY2018 | $0.34 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026